D58.1
Hereditary elliptocytosis
Clinical Classification Guidelines
Inclusion Terms
- Elliptocytosis (congenital)
- Ovalocytosis (congenital) (hereditary)
Medical Intelligence & Overview
Hereditary elliptocytosis is a genetic blood disorder characterized by the presence of oval-shaped or elongated red blood cells. This condition is inherited and affects the shape and flexibility of red blood cells, which can influence their ability to transport oxygen efficiently. Though many individuals with this condition experience mild symptoms or none at all, it is important to understand its implications for health and well-being.
Causes & Symptoms
Clinical Causes: Inherited genetic mutations passed from parents to children Mutations affecting proteins in the red blood cell membrane, leading to its abnormal shape A familial tendency sees this condition appearing in multiple family members In some cases, hereditary elliptocytosis may coexist with other blood disorders, complicating the clinical picture
Key Symptoms: Mild to moderate anemia, resulting in fatigue or weakness Paleness of the skin and mucous membranes Jaundice, or yellowing of the skin and eyes, especially during hemolytic episodes Splenomegaly, which is an enlarged spleen In severe cases, episodes of hemolysis, where red blood cells are destroyed prematurely
Diagnostic & Treatment
Diagnosis Path: Blood tests reveal the presence of oval or elongated red blood cells under a microscope Complete blood count (CBC) shows anemia and other abnormal blood patterns Family history analysis helps identify inherited patterns Specialized tests, such as osmotic fragility tests or membrane protein analysis, assist in confirming the diagnosis Genetic testing may be used to identify specific mutations associated with elliptocytosis
Treatment Protocols: Most individuals with mild symptoms require no specific treatment Regular monitoring by a healthcare professional is recommended to track blood health Folic acid supplements may be prescribed to aid in red blood cell production In cases of significant anemia or hemolysis, treatments like blood transfusions or medications to suppress spleen activity could be considered Splenectomy (removal of the spleen) might be an option in severe cases, although this is evaluated carefully due to potential risks
Clinical Advice & FAQs
Billing Guidance
Is D58.1 a billable ICD-10 code?
Yes, D58.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D58.1?
Clinical documentation must specify the nature of Hereditary elliptocytosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference